Guangdong's Pilot Plan for Hong Kong Medical Devices to enter the China Greater Bay Area

On January 28, 2021, the Guangdong MPA (Medical Products Administration) announced the pilot plan (No.5-2021) to introduce Hong Kong medical devices into the China Greater Bay Area via the University of Hong Kong-Shenzhen Hospital as a start.

In the announcement, the Guangdong MPA addressed the following responsibilities of the different departments involved to support the pilot plan:

DepartmentResponsibilitiesGuangdong MPA
Fully support the pilot phase for the University of Hong Kong-Shenzhen Hospital to use drug and medical device products from Hong Kong and Macao

Formulate a review report and recommendation plan after the pilot phase ends on July 31, 2021

Health Commission
of Guangdong Province

Implement the internal evaluation process and standard requirements for the approval of GBA medical institutions to use drug and medical device products from Hong Kong and Macao


Guangdong Provincial Development and
Reform Commission


Strengthen the policy implementation and follow up for confirmation

Department of Finance
of Guangdong Province
Consolidate the designated medical institutions’ requests for import tariff reductions and submit them to the Ministry of Finance for approval


Guangdong
Sub-administration
of GACC (General Administration of Customs. P.R. China)


Coordinate with the related customs departments of Hong Kong, Macao and the nine Pearl River Delta municipalities to deliver proper custom clearance procedures

The pilot plan came into force on January 28, 2021 and will end on July 31, 2021.

By Jacky Li. Contact Cisema if you would like to learn more.